Valuation: Elekta AB

Market Cap 23.7B 2.41B 2.16B 1.99B 1.8B 3.37B 229B 3.43B 9.52B 121B 9.06B 8.86B 380B P/E 2027 *
15.1x
P/E 2028 * 13.8x
Enterprise Value 27.09B 2.76B 2.47B 2.27B 2.06B 3.85B 262B 3.92B 10.87B 138B 10.35B 10.13B 434B EV / Sales 2027 *
1.57x
EV / Sales 2028 * 1.48x
Free-Float
93.74%
Yield 2027 *
4.08%
Yield 2028 * 4.59%
1 day+0.17%
1 week+3.50%
1 month+13.30%
3 months+17.25%
6 months+1.63%
Current year-3.09%
1 week 5.8
Extreme 5.805
5.97
1 month 5.08
Extreme 5.085
5.97
Current year 4.63
Extreme 4.63
6.93
1 year 4.35
Extreme 4.35
6.93
3 years 4.35
Extreme 4.35
8.62
5 years 4.35
Extreme 4.35
12.96
10 years 4.35
Extreme 4.35
15.56
Manager TitleAgeSince
Chief Executive Officer - 01/09/2025
Director of Finance/CFO - 01/03/2026
Investor Relations Contact - 01/12/2023
Director TitleAgeSince
Director/Board Member 69 30/06/2010
Director/Board Member 70 15/09/2011
Chairman 74 03/09/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+3.50% - - 2.41B
-1.72%+3.44%+22.84%+56.71% 258B
-2.00%+0.75%+7.82%+20.94% 163B
-3.73%-4.48%-19.14%+64.75% 150B
-1.66%-8.12%-58.32%-17.99% 60.84B
-2.57%+3.30%+11.59%+44.40% 53.03B
-.--%+2.46%-11.97%-6.29% 53.31B
-3.47%+1.04%+19.48%+69.17% 49.3B
+0.84%-3.12%+7.47%+62.40% 50.67B
-3.61%+1.99%+32.36%+93.99% 45.46B
Average -1.78%-0.30%+1.35%+43.12% 98.16B
Weighted average by Cap. -2.10%+0.15%+4.00%+44.71%

Financials

2027 *2028 *
Net sales 17.3B 1.76B 1.58B 1.45B 1.31B 2.46B 167B 2.5B 6.94B 87.94B 6.61B 6.47B 277B 18.02B 1.83B 1.64B 1.51B 1.37B 2.56B 174B 2.61B 7.23B 91.62B 6.88B 6.74B 289B
Net income 1.51B 154M 138M 127M 115M 215M 14.6B 219M 606M 7.68B 577M 565M 24.22B 1.66B 169M 151M 139M 126M 236M 16.04B 240M 666M 8.44B 634M 620M 26.6B
Net Debt 3.38B 344M 308M 284M 257M 481M 32.71B 490M 1.36B 17.2B 1.29B 1.27B 54.26B 2.88B 294M 263M 242M 219M 410M 27.87B 417M 1.16B 14.66B 1.1B 1.08B 46.24B
Projected Income Statement - Annual - Elekta AB
Logo Elekta AB
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.
Employees
3,996
Date Price Change Volume
30/10/26 USD 5.920 +0.17% 386
28/10/26 USD 5.910 +1.81% 1,671
26/10/26 USD 5.805 +1.49% 306
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Elekta AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
59.70SEK
Average target price
57.71SEK
Spread / Average Target
-3.33%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Elekta AB